Max Mitteregger
Fortune : 7 M $ au 31/05/2026
Fortune : 7 M $ au 31/05/2026
Mr. Max H.
Mitteregger is a Founder & Owner at Max Mitteregger Kapitalförvaltning AB. He is on the Board of Directors at Max Mitteregger Kapitalförvaltning AB.
He has about 25 years of experience working in the financial sector, including as a partner, one of the founders and Head of Equity Sales at ABG Sundal Collier and Head of Sales at Carnegie.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
Humana AB
Humana AB Other Consumer ServicesConsumer Services Offers individual and family care services, personal assistance, and elderly care 2,25 % | 31/12/2024 | 1 165 000 ( 2,25 % ) | 7 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
Max Mitteregger Kapitalförvaltning AB
Max Mitteregger Kapitalförvaltning AB Investment ManagersFinance MMK aims to over time and with a balanced risk-taking give the shareholders an absolute return on invested capital, regardless of the general market. The firm invests the Fund in long positions that are expected to increase in value and short positions that are expected to decrease in value. The fund’s assets are invested in transferable securities, money market instruments, derivatives (including OTC derivatives), exchange traded funds (known as ETFs) and on account with credit institutes. | Fondateur | 24/11/2004 |
Galba Holding AB | Directeur Général | - |
| Sociétés | Poste | Fin |
|---|---|---|
| LIDDS AB | Directeur/Membre du Conseil | 02/07/2023 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Max Mitteregger Kapitalförvaltning AB
Max Mitteregger Kapitalförvaltning AB Investment ManagersFinance MMK aims to over time and with a balanced risk-taking give the shareholders an absolute return on invested capital, regardless of the general market. The firm invests the Fund in long positions that are expected to increase in value and short positions that are expected to decrease in value. The fund’s assets are invested in transferable securities, money market instruments, derivatives (including OTC derivatives), exchange traded funds (known as ETFs) and on account with credit institutes. | Finance |
LIDDS AB
LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
Galba Holding AB |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national